RPL12P15

Across TCGA pan-cancer cohorts, RPL12P15 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RPL12P15 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RPL12P15 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL12P15 expression acts as an unfavorable survival marker, although some lineages such as BRCA and THCA show a favorable association.

BRCA, THCA, and ACC are the cancer types where RPL12P15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Median	III,IV	0.885	0.701	<.001	40	view →
THCA	OS	Median	All	0.986	0.898	<.001	36	view →
ACC	DFS	Tertile	All	0.277	0.707	.008	30	view →
THYM	DFS	Quartile	II,III,IV	0.982	0.728	.006	20	view →
KIRP	DFS	Median	All	0.364	0.725	.001	19	view →
LIHC	DFS	Tertile	All	0.494	0.630	.009	18	view →
SARC	DFS	Quartile	All	0.226	0.571	.001	14	view →
STAD	DFS	Quartile	All	0.440	0.717	.007	12	view →
MESO	DFS	Median	III,IV	0.632	0.264	.011	12	view →
CESC	DFS	Tertile	IV	0.319	0.783	.003	12	view →
ESCA	OS	Quartile	III,IV	0.687	0.285	.008	7	view →
SKCM	DFS	Median	IV	0.551	0.203	.018	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RPL12P15–BRCA (DFS)

Open the BRCA breakdown →